You are an early-stage venture capitalist conducting due diligence on a biotech start-up. You are willing to contribute $2,000,000 in the first round of financing, and you target a final exit multiple of 10 invested capital, which estimate will happen in ten years. At that time, you estimate the firm will sell for $90,000,000. You expect an additional round of financing in four years in which you will not participate that will dilute your ownership share by 50%. What must be your initial valuation of the company excluding the amount of your investment? Multiple Choice $2,000,000 $90,000,000 None of the options are correct. $2,500,000 $4,500,000